Esperion Therapeutics
ESPR
#7380
Rank
A$0.57 B
Marketcap
$2.93
Share price
-0.53%
Change (1 day)
-28.19%
Change (1 year)

Esperion Therapeutics (ESPR) - P/B ratio

P/B ratio as of February 2025 : -1.00

According to Esperion Therapeutics's latest financial reports the company has a price-to-book ratio of 1.25376.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Esperion Therapeutics - P/B ratio (from 2013 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31-1.2162.38%
2023-12-31-0.7473-47.29%
2022-12-31-1.42-8.3%
2021-12-31-1.55-77.94%
2020-12-31-7.01-108.53%
2019-12-3182.2426.99%
2018-12-3115.6121.25%
2017-12-317.05470.68%
2016-12-311.24-29.21%
2015-12-311.74-71.67%
2014-12-316.16116.53%
2013-12-312.84
2012-12-31N/A
2003-12-31N/A
2002-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
11.0-1,196.80%๐Ÿ‡บ๐Ÿ‡ธ USA
2.27-326.77%๐Ÿ‡บ๐Ÿ‡ธ USA
1.57-256.68%๐Ÿ‡บ๐Ÿ‡ธ USA
2.52-352.30%๐Ÿ‡บ๐Ÿ‡ธ USA
16.3-1,727.37%๐Ÿ‡บ๐Ÿ‡ธ USA
1.60-259.54%๐Ÿ‡บ๐Ÿ‡ธ USA